Nanoparticle vaccines with novel structural components
US11097002B2 · kind B2 · utility
3Cited by
3References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2019 |
| Grant date | Aug 24, 2021 |
| Priority date | — |
| Expiry date | Jul 29, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel nanoparticle presented vaccine compositions that are stabilized with a locking domain. Various immunogens can be employed in the preparation of the vaccine compositions, including viral immunogens such as HIV-1 and Ebola viral immunogens, and non-viral immunogens such as immunogens derived from bacteria, parasites and mammalian species. The invention also provides methods of using such vaccine compositions in various therapeutic applications, e.g., for preventing or treating viral infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.